← Eichor
Study identifier: NCT06883006 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Regulation of Emotion, Sleep Extension, and mTBI

Condition: Mild Traumatic Brain Injury  ·  Sponsor: Merrimack College

PhasePhase 1
Planned participants60
Who can joinAll sexes, 18 Years to 35 Years
Healthy volunteersNo

About this study

Concussions are incredibly common, and often result in severe and long lasting symptoms, including, but not limited to, sleep deprivation and emotion dysregulation. This study aims to demonstrate the therapeutic benefits of sleep extension (napping) on emotion regulation in individuals after they sustain a concussion. Thus, sleep extension may be a cost-effective, low risk, supplemental treatment for those with emotion dysregulation following a concussion. The main questions it aims to answer are: 1. Is a nap an effective way to improve emotion regulation in individuals with a concussion? 2. Does a nap reduce the required executive resources necessary to regulate emotions in individuals with a concussion?

This description comes directly from the study's public registry record.

Talk to the study team

Laura Kurdziel, PhD  ·  978-837-5361  ·  kurdziell@merrimack.edu

Allison Seitchik, PhD  ·  978-837-3575  ·  seitchika@merrimack.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Merrimack CollegeNorth Andover, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06883006